4.6 Article

Transcriptional Co-activator p300 Maintains Basal Hepatic Gluconeogenesis

Journal

JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 287, Issue 38, Pages 32069-32077

Publisher

AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.M112.385864

Keywords

-

Funding

  1. NIDDK, National Institutes of Health [K99DK085142, R00DK085142, R01DK063349]
  2. Baltimore Diabetes Research and Training Center [P60DK079637]

Ask authors/readers for more resources

A major cause of fasting hyperglycemia in diabetes mellitus is unregulated hepatic glucose production (HGP). Insulin suppresses HGP by phosphorylating CBP and disassembling the CREB-CBP complex from gluconeogenic genes. p300 is closely related to CBP; but in contrast to CBP, p300 binds constitutively to CREB due to the absence of phosphorylation site found in CBP. In a phosphorylation-competent p300(G442S) knock-in mouse model, we demonstrate that HGP is now exquisitely sensitive to insulin suppression. p300(G422S) and hepatic-deleted p300 mice exhibited significant lower blood glucose levels in the fasted and post-prandial states, indicating a role for p300 in maintaining basal HGP.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available